IP Library Granted Patent US 9,033,950
Granted Patent B2
US 9,033,950 · App. 13/194,328 · Granted May 19, 2015

Method for transdermal delivery of permeant substances

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,033,950
App. No.
13/194,328
Granted
May 19, 2015
Kind
B2
Abstract

A method for delivering permeant substances transdermally into a membrane of an animal includes forming at least one delivery opening in the skin tissue, with the at least one delivery opening having a mean opening depth of between about 40 and about 90 microns.

Claims (14)

1. A method for delivering permeant substances through a biological membrane of an animal comprising forming a plurality of delivery openings in the membrane, wherein an opening depth of the majority of said delivery openings falls within the range between 40 and 90 microns, and delivering a permeant through the plurality of delivery openings by placing a patch comprising the permeant over the plurality of delivery openings,

wherein the plurality of delivery openings are formed by microporation conducted with positive pressure being present between a microporator and said membrane, wherein said positive pressure results from a vacuum of about 0.25 to about 0.80 bar being applied between said microporator and said membrane.

2. The method of claim 1 wherein the opening depth of a majority of said delivery openings falls within the range of 50 to 70 microns.

3. The method of claim 2 wherein 75% of said delivery openings have an opening depth falling within the range of 50 to 70 microns.

4. The method of claim 3 wherein 75% of said delivery openings have an opening depth falling within the range of 55 microns to 65 microns.

5. The method of claim 1 wherein said delivery openings have a range of opening depths falling within one standard deviation of 50 microns to 70 microns.

6. The method of claim 5 wherein said delivery openings have a range of opening depths falling within one standard deviation of 60 microns.

7. The method of claim 1 wherein said delivery openings have a range of opening depths falling within one standard deviation of 90 microns.

8. The method of claim 1 wherein the plurality of delivery openings are formed by a planar array microporation device.

9. The method of claim 1 wherein the plurality of delivery openings are formed by a microporator selected from the group consisting of a heated probe element capable of conductively delivering thermal energy via direct contact to a biological membrane to cause the ablation of some portion of the membrane deep enough to form a micropore, the heated probe comprising an electrically heated resistive element capable of ablating a biological membrane or an optically heated topical dye/absorber layer, electro-mechanical actuator, a microlancet, an array of microneedles (solid or hollow), microprojections, microcstructures or lancets, a sonic energy ablator, a laser ablation system, and a high pressure fluid jet puncturer.

10. A method for delivering drugs transdermally into a biological membrane of an animal comprising forming a plurality of delivery openings through a membrane, wherein said delivery openings have a distribution resulting in a bell-shaped curve with said delivery openings having a mean opening depth of between 40 and 90 microns, and delivering a drug through the plurality of delivery openings by placing a patch comprising the drug over the plurality of delivery openings,

wherein the plurality of delivery openings are formed by microporation conducted with positive pressure being present between a microporator and said membrane, wherein said positive pressure results from a vacuum of about 0.25 to about 0.80 bar being applied between said microporator and said membrane.

11. The method of claim 1 wherein said positive pressure results from a vacuum of about 0.50 bar being applied between said device and said membrane.

12. The method of claim 10 wherein said positive pressure results from a vacuum of about 0.50 bar being applied between said device and said membrane.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: NITTO DENKO CORPORATION
To: PASSPORT TECHNOLOGIES, INC.
Reel/Frame 050912/0318 →
TRANSFER STATEMENT Recorded Oct 21, 2014
From: MIDCAP FUNDING III, LLC., AS ADMINISTRATIVE AGENT FOR THE LENDERS
To: NITTO DENKO CORPORATION
Reel/Frame 034029/0552 →
ASSET PURCHASE AGREEMENT Recorded Oct 20, 2014
From: MIDCAP FUNDING III, LLC
To: NITTO DENKO CORPORATION
Reel/Frame 034017/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2013
From: MIDCAP FUNDING III, LLC
To: NITTO DENKO CORPORATION
Reel/Frame 029637/0286 →